Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling

Journal of Neuro-Oncology

Volumn 50, Issue 1-2, 2000, Pages 1-15

  Patan, S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Angiogenesis; Angiopoietins tie receptors; Ephrin B EpH B receptors; Intussusceptive microvascular growth; Vasculogenesis; VEGF

Indexed keywords

ANGIOPOIETIN; EPHRIN; EPHRIN RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; EMBRYOLOGY; EMBRYONAL TISSUE; ENDOTHELIUM CELL; HEART DEVELOPMENT; HEMANGIOBLASTOMA; HUMAN; MICROVASCULATURE; MOLECULAR RECOGNITION; NEOVASCULARIZATION (PATHOLOGY); REGULATORY MECHANISM; REVIEW; TISSUE GROWTH; VASCULAR TISSUE; VASCULARIZATION;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; CARDIOVASCULAR SYSTEM; CHICK EMBRYO; ENDOTHELIAL GROWTH FACTORS; EPHRIN-B1; HUMANS; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MESODERM; MICE; MODELS, BIOLOGICAL; MORPHOGENESIS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN ISOFORMS; PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPHB4; RECEPTOR, TIE-2; RECEPTORS, CELL SURFACE; RECEPTORS, EPH FAMILY; RECEPTORS, TIE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034470341     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006493130855     Document Type: Review

References (132)

1. Vasculogenesis and angiogenesis: Two distinct morphogenetic mechanisms establish embryonic vascular pattern
2. Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo
3. Multiple developmental roles of VEGF suggested by a LacZ-tagged allele
4. Implementation of intussusceptive microvascular growth in the chicken chorioallantoic membrane (CAM): Pillar formation by folding of the capillary wall
5. Implementation of intussusceptive microvascular growth in the chicken chorioallantoic membrane (CAM): Pillar formation by capillary fusion
6. TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth
7. Vasculogenesis, angiogenesis and endothelial cell differentiation during embryonic development
8. Mechanisms of angiogenesis
9. Vascularization phenomena in fragments of embryonic bodies completely isolated from yolk-sac blastoderm
10. The origin of blood and vascular endothelium in embryos without a circulation of the blood and in the normal embryo
11. Studies on the origin of blood-vessels and of red blood-corpuscles as seen in the living blastoderm of chicks during the second day of incubation
12. Vasculogenesis
13. Vasculogenesis in the early quail blastodisc as studied with a monoclonal antibody recognizing endothelial cells
14. Relationship between vasculogenesis, angiogenesis and hematopoiesis during avian ontogeny
15. Origin and development of the primitive vessels of the chick and of the pig
16. Morphogenetic mechanisms in avian vascular development
17. The formation of avian embryonic blood vessels
18. Cell migration in embryos
19. Vascular endothelial cells migrate centripetally within the embryonic arteries
20. First blood vessels in the avian neural tube are formed by a combination of dorsal angioblast immigration and ventral sprouting of endothelial cells
21. Two distinct endothelial lineages in ontogeny, one of them related to hemopoiesis
22. Is extraembryonic angiogenesis in the chick embryo controlled by the endoderm?
23. Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo
24. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system
25. Failure of blood-island formation and vasculogenesis in FLk-1-deficient mice
26. Requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis
27. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligands suggests a paracrine regulation of murine vascular development
28. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
29. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
30. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
31. Defective hematopoiesis and vasculogenesis in transforming growth-factor-beta1 knockout mice
32. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis
33. Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity
34. The cloche and spadetail genes differentially affect hematopoiesis and vasculogenesis
35. The position of the respiratory vascular net in the allantois of the chick
36. Studies on the growth of blood vessels, by observation of living tadpoles and by experiments on chick embryos
37. Studies on the growth of blood-vessels in the tail of the frog larva - By observation and experiment on the living animal
38. Microscopic observations on the growth of blood capillaries in the living mammal
39. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis
40. Tumor growth and neovascularization: An experimental model using the rat cornea
41. A simple procedure for long-term cultivation of chicken embryos
42. Polymers for the sustained release of proteins and other macromolecules
43. Growth and metastasis of tumor organ culture
44. Tumor angiogenesis: Therapeutic implications
45. Anti-angiogenesis: New concept for therapy of solid tumors
46. Long-term culture of capillary endothelial cells
47. Angiogenesis in vitro
48. In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices
49. Capillary endothelial cell cultures: Phenotypic modulation by matrix components
50. Purification by affinity chromatography on heparin-sepharose of a growth factor that stimulates capillary endothelial cells
51. Heparin affinity: Purification of a tumor-derived capillary endothelial cell growth factor
52. Angiogenesis: Initiation and control
53. Tumor angiogenesis
54. How is blood vessel growth regulated in normal and neoplastic tissue?
55. Alveolar epithelium in relation to growth of the lung
56. Scanning electron microscope study of the developing microvasculature in the postnatal rat lung
57. A novel mechanism of capillary growth in the rat pulmonary microcirculation
58. Myocardial capillaries: Increase in number by splitting of existing vessels
59. Intussusceptive microvascular growth: A common alternative to endothelial sprouting
60. Evidence for intussusceptive capillary growth in the chicken chorio-allantoic membrane (CAM)
61. Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: A novel mechanism of tumor angiogenesis
62. Shear stress gradients remodel endothelial monolayers in vitro via a cell proliferation-migration-loss cycle
63. Regulation of PDGF-B in endothelial cells exposed to cyclic strain
64. Vascular endothelial cells respond to spatial gradients in fluid shear stress by enhanced activation of transcription factors
65. Requisite role of Angiopoietin-1, a ligand for the TIE2 receptor during embryonic angiogenesis
66. Angiogenesis in ischemic heart disease
67. Isolation of angiopoietin-1, a ligand for the angiogenic TIE2 receptor, by secretion-trap expression cloning
68. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4
69. Roles of ephrin-B ligands and EphB receptors in cardiovascular development: Demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis
70. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors: Generation of receptor-selective VEGF variants by site-directed mutagenesis
71. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms and VEGF164 and VEGF188
72. Vascular endothelial growth factor up-regulates its receptor fms-like kinase 1 (Flt-1) and a soluble variant of Flt-1 in human vascular endothelial cells
73. Vascularization of the mouse embryo: A study of flk-1, tek, tie, and vascular endothelial growth factor expression during development
74. A novel endothelial surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains
75. Molecular cloning and characterization of mouse Tie and Tek receptor tyrosine kinase genes and their expression in hematopoietic stem cells
76. Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family
77. tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system
78. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage
79. Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta
80. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo
81. Distinct roles of the receptor tyrosine kinases and TIE1 and TIE2 in blood vessel formation
82. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells
83. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2
84. Angiopoietin-1 induces sprouting angiogenesis in vitro
85. Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors
86. Increased vascularization in mice overexpressing angiopoietin-1
87. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
88. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
89. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity
90. Vascular reaction of normal and malignant tumors in vivo. I. Vascular reactions of mice to wounds and to normal and neoplastic transplants
91. Tumor angiogenesis: Transfilter diffusion studies in the hamster by the transparent chamber technique
92. Induction of angiogenesis during the transition from hyperplasia to neoplasia
93. A tumor suppressor-dependent inhibitor of angiogenesis immunologically and functionally indistinguishable from a fragment of thrombospondin
94. Thrombospondin as a regulator of angiogenesis
95. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
96. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
97. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth
98. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene
99. Tumor angiogenesis: The role of oncogenes and tumor suppressor genes
100. Angiogenesis in cancer, vascular, rheumatoid and other disease
101. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
102. Determinants of tumor blood flow: A review
103. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing
104. Pathogenesis of ascites tumor growth: Angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining
105. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
106. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
107. Hypoxia mediated induction of acidic/basic fibroblast growth factor and platelet derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells
108. Clinical applications of research on angiogenesis
109. Role of vascular endothelial growth factor in the regulation of angiogenesis
110. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis
111. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
112. Glioblastoma growth inhibited in vivo by a dominant-negative FLK-1 mutant
113. Dominant-negative inhibition of FLK-1 suppresses the growth of many tumor types in vivo
114. Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular matrix domain of flt-1 vascular endothelial growth factor receptor
115. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis and mortality rate
116. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase tie2
117. Two independent mechanisms essential for tumor angiogenesis: Inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the tie-2 pathway
118. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
119. The endothelial receptor tyrosine kinase tie-1 is upregulated by hypoxia and vascular endothelial growth factor
120. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth
121. Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization
122. Up-regulation of vascular endothelial growth factor expression induced by myocardial ischemia: Implications for coronary angiogenesis
123. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb
124. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis
125. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb
126. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease
127. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
128. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
129. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin